Victory Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.8K | Sell |
12,766
-1,450
| -10% | -$3.49K | ﹤0.01% | 2416 |
|
|
2025
Q1 | $31.4K | Sell |
14,216
-82,057
| -85% | -$181K | ﹤0.01% | 2400 |
|
|
2024
Q4 | $525K | Buy |
96,273
+37,946
| +65% | +$207K | ﹤0.01% | 2024 |
|
|
2024
Q3 | $485K | Buy |
58,327
+44,180
| +312% | +$367K | ﹤0.01% | 2011 |
|
|
2024
Q2 | $101K | Sell |
14,147
-19,223
| -58% | -$138K | ﹤0.01% | 2295 |
|
|
2024
Q1 | $289K | Sell |
33,370
-77,098
| -70% | -$668K | ﹤0.01% | 2129 |
|
|
2023
Q4 | $724K | Buy |
110,468
+77,727
| +237% | +$509K | ﹤0.01% | 1856 |
|
|
2023
Q3 | $327K | Buy |
32,741
+9,151
| +39% | +$91.5K | ﹤0.01% | 2098 |
|
|
2023
Q2 | $293K | Buy |
23,590
+749
| +3% | +$9.31K | ﹤0.01% | 2123 |
|
|
2023
Q1 | $320K | Buy |
22,841
+10,450
| +84% | +$146K | ﹤0.01% | 2129 |
|
|
2022
Q4 | $177K | Sell |
12,391
-15,138
| -55% | -$217K | ﹤0.01% | 2286 |
|
|
2022
Q3 | $703K | Buy |
27,529
+4,151
| +18% | +$106K | ﹤0.01% | 1898 |
|
|
2022
Q2 | $664K | Sell |
23,378
-137
| -0.6% | -$3.89K | ﹤0.01% | 1939 |
|
|
2022
Q1 | $723K | Buy |
23,515
+1,904
| +9% | +$58.5K | ﹤0.01% | 1974 |
|
|
2021
Q4 | $906K | Sell |
21,611
-2,392
| -10% | -$100K | ﹤0.01% | 1883 |
|
|
2021
Q3 | $1.18M | Sell |
24,003
-71,514
| -75% | -$3.51M | ﹤0.01% | 1784 |
|
|
2021
Q2 | $3.99M | Sell |
95,517
-4,557
| -5% | -$190K | ﹤0.01% | 1420 |
|
|
2021
Q1 | $3.57M | Sell |
100,074
-4,953
| -5% | -$177K | ﹤0.01% | 1461 |
|
|
2020
Q4 | $2.95M | Buy |
+105,027
| New | +$2.95M | ﹤0.01% | 1390 |
|